cycloheximide has been researched along with Syndrome in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Arnesen, T; Bader, I; Boltshauser, E; Darbakk, C; Ebner, S; Mayr, JA; McTiernan, N; Ree, R | 1 |
| Eng, C; Waite, KA | 1 |
| Parry, EW | 2 |
| Fujii, H; Gomi, M; Iida, S; Kitani, T; Moriwaki, K; Tsugawa, M | 1 |
| Bravo, M; Pincheira, J; Santos, MJ | 1 |
| Kirk-Bell, S; Lehmann, AR; Mayne, L | 1 |
| Fauci, AS; Parrillo, JE | 1 |
| Brul, S; Heymans, HS; Schram, AW; Schutgens, RB; Strijland, A; Tager, JM; Van den Bosch, H; Wanders, RJ; Westerveld, A; Wiemer, EA | 1 |
9 other study(ies) available for cycloheximide and Syndrome
| Article | Year |
|---|---|
Severe syndromic ID and skewed X-inactivation in a girl with NAA10 dysfunction and a novel heterozygous de novo NAA10 p.(His16Pro) variant - a case report.
Topics: Amino Acid Sequence; Biocatalysis; Child; Cycloheximide; Female; HeLa Cells; Heterozygote; Humans; Intellectual Disability; Male; Mutation; N-Terminal Acetyltransferase A; N-Terminal Acetyltransferase E; Pedigree; Syndrome; X Chromosome Inactivation | 2020 |
BMP2 exposure results in decreased PTEN protein degradation and increased PTEN levels.
Topics: Blotting, Western; Bone Morphogenetic Protein 2; Bone Morphogenetic Protein Receptors, Type I; Bone Morphogenetic Proteins; Breast Neoplasms; Cell Division; Cell Movement; Cycloheximide; Dose-Response Relationship, Drug; Genetic Predisposition to Disease; Humans; Ligases; Mutation; Phosphoric Monoester Hydrolases; Precipitin Tests; Protein Serine-Threonine Kinases; Protein Synthesis Inhibitors; PTEN Phosphohydrolase; Receptors, Growth Factor; Syndrome; Time Factors; Transforming Growth Factor beta; Tumor Cells, Cultured; Tumor Suppressor Proteins; Ubiquitin-Conjugating Enzymes | 2003 |
A lethal syndrome in mice following administration of carbon tetrachloride and cycloheximide, and its prevention by heparin treatment.
Topics: Animals; Carbon Tetrachloride Poisoning; Cycloheximide; Drug Interactions; Heparin; Male; Mice; Mice, Inbred CBA; Syndrome; Time Factors | 1984 |
The lethal syndrome following intravenous injection of Ehrlich ascites tumour cells in cycloheximide-treated mice and its prevention by heparin.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cycloheximide; Heparin; Liver; Male; Mice; Mice, Inbred Strains; Protein Biosynthesis; Syndrome | 1984 |
Augmented induction by dexamethasone of metallothionein IIa messenger ribonucleic acid in fibroblasts from a patient with cortisol hyperreactive syndrome.
Topics: Adrenal Glands; Cycloheximide; Dexamethasone; Endocrine System Diseases; Fibroblasts; Humans; Hydrocortisone; Kinetics; Metallothionein; RNA, Messenger; Syndrome; Zinc | 1993 |
G2 repair in Nijmegen breakage syndrome: G2 duration and effect of caffeine and cycloheximide in control and X-ray irradiated lymphocytes.
Topics: Abnormalities, Multiple; Caffeine; Cells, Cultured; Child, Preschool; Chromosome Breakage; Cycloheximide; DNA Repair; Female; G2 Phase; Humans; Lymphocytes; Male; Syndrome; Time Factors; X-Rays | 1998 |
Abnormal kinetics of DNA synthesis in ultraviolet light-irradiated cells from patients with Cockayne's syndrome.
Topics: Cells, Cultured; Cycloheximide; DNA; DNA Repair; Floxuridine; Humans; Photosensitivity Disorders; Syndrome; Time Factors; Ultraviolet Rays | 1979 |
Human eosinophils. Purification and cytotoxic capability of eosinophils from patients with the hypereosinophilic syndrome.
Topics: Antibody-Dependent Cell Cytotoxicity; Cell Separation; Cycloheximide; Eosinophilia; Eosinophils; Humans; Immunoglobulin Fc Fragments; Neutrophils; Phagocytes; Phagocytosis; Receptors, Antigen, B-Cell; Rosette Formation; Syndrome | 1978 |
Kinetics of the assembly of peroxisomes after fusion of complementary cell lines from patients with the cerebro-hepato-renal (Zellweger) syndrome and related disorders.
Topics: Brain Diseases; Catalase; Cell Fusion; Cell Line; Cycloheximide; Fibroblasts; Humans; Kidney Diseases; Liver Diseases; Microbodies; Syndrome | 1988 |